GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Aetna Inc (NYSE:AET) » Definitions » EBITDA per Share

Aetna (AET) EBITDA per Share : $18.15 (TTM As of Sep. 2018)


View and export this data going back to 1968. Start your Free Trial

What is Aetna EBITDA per Share?

Aetna's EBITDA per Share for the three months ended in Sep. 2018 was $4.81. Its EBITDA per Share for the trailing twelve months (TTM) ended in Sep. 2018 was $18.15.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for Aetna's EBITDA per Share or its related term are showing as below:

AET's 3-Year EBITDA Growth Rate is not ranked *
in the Healthcare Plans industry.
Industry Median: 2.7
* Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.

Aetna's EBITDA for the three months ended in Sep. 2018 was $1,588 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.


Aetna EBITDA per Share Historical Data

The historical data trend for Aetna's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aetna EBITDA per Share Chart

Aetna Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.70 12.43 14.96 14.89 12.34

Aetna Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.59 2.51 5.12 5.72 4.81

Aetna EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Aetna's EBITDA per Share for the fiscal year that ended in Dec. 2017 is calculated as

EBITDA per Share(A: Dec. 2017 )
=EBITDA/Shares Outstanding (Diluted Average)
=4139/335.400
=12.34

Aetna's EBITDA per Share for the quarter that ended in Sep. 2018 is calculated as

EBITDA per Share(Q: Sep. 2018 )
=EBITDA/Shares Outstanding (Diluted Average)
=1588/330.200
=4.81

EBITDA per Share for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aetna  (NYSE:AET) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


Aetna EBITDA per Share Related Terms

Thank you for viewing the detailed overview of Aetna's EBITDA per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Aetna (AET) Business Description

Traded in Other Exchanges
N/A
Address
Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This large member count helps the firm diversify its operating risk and has formed the basis for material competitive advantages. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna and CVS recently announced their intention to merge operations, and if approved, it would form one of the most powerful players within the healthcare space.
Executives
Fernando Aguirre director CHIQUITA BRANDS INTERNATIONAL, 250 EAST FIFTH STREET, CINCINNATI OH 45202
Harold L Paz officer: EVP & Chief Medical Officer AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Molly Joel Coye director AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156
Jeffrey E Garten director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Frank M Clark director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Shawn M Guertin officer: Exec. Vice President, CFO TRINET GROUP, INC., ONE PARK PLACE, SUITE 600, DUBLIN CA 94568
Mark T Bertolini director, officer: Chairman and CEO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Karen S Lynch officer: President 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Roger N Farah director POLO RALPH LAUREN CORP, 650 MADISON AVE, NEW YORK NY 10022
Ellen M Hancock director 126 LIMESTONE ROAD, RIDGEFIELD CT 06877
Edward J Ludwig director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Margaret M Mccarthy officer: EVP, Operations & Technology AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Olympia J. Snowe director 100 E. PRATT STREET, BALTIMORE MD 21202
Heather Brianne Dixon officer: VP, Controller & CAO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Sabatino Thomas J Jr officer: EVP & General Counsel C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015

Aetna (AET) Headlines

From GuruFocus

Weekly 52-Week Highs Highlight: AET, BK, EQIX, MGA

By Jimmy Xiao gurujx 05-11-2015

Analysts Take Action on Health Care Stocks

By Alberto Abaterusso Alberto Abaterusso 01-23-2018

Here's a Stock-Market Tool That Isn't Used Much

By John Dorfman John Dorfman 07-20-2016

14 Best Undervalued Stocks of the Week

By Benjamin Clark Benjamin Clark 08-09-2016

5 Health Care Stocks Gurus Are Buying

By Tiziano Frateschi Tiziano Frateschi 10-30-2018

Aetna: Solid Prospects in a Volatile Environment

By Robert Abbott Robert Abbott 03-31-2015

David Dreman's Top 5 Health Care Buys for the 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood 08-25-2017